Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Proinflammatory CD20+ T cells in the pathogenesis of multiple sclerosis

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. PET imaging of meningioma with 18F-FLT: a predictor of tumour progression

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Functional gene networks reveal distinct mechanisms segregating in migraine families

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. New genotype-phenotype correlations in a large European cohort of patients with sarcoglycanopathy

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. The apparently milder course of multiple sclerosis: changes in the diagnostic criteria, therapy and natural history

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Novel congenital disorder of O-linked glycosylation caused by GALNT2 loss of function

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Genome-wide association study of circulating levels of glucagon during an oral glucose tolerance test

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Treatment- and population-specific genetic risk factors for anti-drug antibodies against interferon-beta: a GWAS

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Biomarkers of inflammation and epithelial barrier function in multiple sclerosis

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

With the discovery that the highly effective anti-CD20 antibody therapies developed to deplete CD20+ B cells deplete CD20+ T cells equally well, a great interest in the biological properties of CD20+ T cells has emerged. In this study we show that CD20+ T cells have a proinflammatory Th1/Tc1 phenotype with a high proliferative capacity to CNS antigens. We also found that the percentage of CD20+ T cells is increased in the blood of patients with multiple sclerosis and are enriched in the CSF of the patients. Furthermore, we found a positive correlation between CD20+ T cells in the CSF and multiple sclerosis disease severity and see that regulation of CD20+ T cells likely contributes to the positive treatment effect of the multiple sclerosis treatment alemtuzumab. These data represent an important contribution to the understanding of the nature of CD20+ T cells and strongly suggests a role of CD20+ T cells in the pathogenesis of multiple sclerosis.

Original languageEnglish
JournalBrain : a journal of neurology
Volume142
Issue number1
Pages (from-to)120-132
Number of pages13
ISSN0006-8950
DOIs
Publication statusPublished - 1 Jan 2019

    Research areas

  • Adult, Alemtuzumab/therapeutic use, Antigens, CD20/blood, Cell Proliferation/drug effects, Cytokines/metabolism, Female, Flow Cytometry, Humans, Male, Middle Aged, Multiple Sclerosis/blood, Multiple Sclerosis, Chronic Progressive/blood, T-Lymphocytes/drug effects, Young Adult

ID: 57911466